Unifund
Based on the provided context, Unifund is a venture capital firm that appears to be based in Greece and focused on investing in early-stage startups. An article on startupper.gr mentions an €850,000 investment by Unifund in Tekmon and CollegeLink, indicating a focus on supporting Greek startups. While the specific investment thesis isn't explicitly detailed, the focus on Greek startups and investments in companies like Tekmon and CollegeLink suggest an interest in technology-driven businesses with growth potential. Further research would be needed to define a comprehensive investment thesis and strategy description for the firm.
Unigestion
Unigestion is an international boutique asset manager with over 50 years of experience, providing investment solutions for institutional clients and high net worth individuals. Their approach is centered on building long-term partnerships and employing an investment methodology tested across numerous market cycles to deliver consistent returns. They focus on innovation, expertise, and performance. ESG criteria are integrated into their investment processes to manage risk and positively influence long-term, risk-adjusted performance. Their core expertise lies in Private Equity, Equities, and Wealth Management. In Private Equity, they aim to deliver attractive returns and steady distributions by investing in the champions of tomorrow. In Equities, they combine the power of mind and machine to achieve unconstrained returns. Their Wealth Management supports discerning families with tailored investment solutions and expert services. Unigestion invests in emerging managers in private equity, acknowledging the perceived risks but emphasizing that these managers often possess deep expertise and proven track records. They focus on specialized knowledge and operational improvements rather than financial engineering. Unigestion believes emerging managers can outperform established managers with the same level of risk, create value differently, and offer attractive risk-adjusted returns for investors.
Unilever Ventures
Unilever Ventures is the venture and growth capital arm of Unilever, focusing on supporting forward-thinking founders who are building brands for the modern consumer. They aim to empower entrepreneurs with big ideas, helping them create strong brands or technology solutions that stand out and move the world forward. With over twenty years of experience, they bring expertise and leadership in the consumer goods industry, offering a unique blend of the global reach of Unilever and the agility of a skilled venture capital team. They seek to back brands of tomorrow and the technologies that enable them to succeed in large markets. Their investments span across beauty and wellness brands, commerce and enabling technologies, and B2B/enterprise technologies. They are particularly interested in emerging brands operating across both digital and physical worlds that are relatable and authentic, as well as services and technologies that enhance the consumer experience and transmute commerce. Their approach is tailored to the specific needs of consumer startups, providing access to Unilever's global network, operational expertise, and deep understanding of consumer preferences. Unilever Ventures provides a platform to help companies scale efficiently and reach a broad consumer base. By combining the resources of a corporate giant with the nimbleness of a venture capital firm, they aim to provide the "best of both worlds" to their portfolio companies. Ultimately, Unilever Ventures invests in companies that align with Unilever's broader mission of creating brands that consumers love, supporting innovation and sustainability, and driving positive change in the world. The firm offers value beyond capital, with expertise in building brands and scaling businesses.
Uniqa Ventures
Uniqa Ventures is not directly mentioned in the crawled pages. The provided content focuses on UNIQA Österreich Versicherungen AG, an Austrian insurance company. The company offers a range of insurance products, including private health insurance, and emphasizes sustainability in its operations. They aim to achieve climate neutrality in Austria by 2040 and in CEE countries by 2050. They operate with a focus on ESG criteria for investments and product development. The company also provides customer service and information through its website and other channels.
United Angels Network
United Angels Network invests in promising Ukrainian startups to grow the Ukrainian startup ecosystem and increase investment value.
University of East Anglia
Based on the crawled pages, it is difficult to create a comprehensive investment thesis for the University of East Anglia (UEA) as a venture capital firm. The university's website primarily focuses on providing information to prospective students, current students, and staff. The available content highlights academic programs, research, campus life, and university policies. There is no indication that the university directly operates as a VC firm with a specific investment thesis. UEA focuses on providing quality education and research opportunities, promoting employability of its graduates, and maintaining a safe and inclusive environment.
University of Strathclyde
Based on the provided information, the University of Strathclyde primarily focuses on education and research. Its investment, if any, is likely directed towards academic research initiatives, supporting students, and infrastructure development within the university itself. The university aims to provide a safe and supportive learning environment, emphasizing the importance of research in informing teaching and contributing to business, industry, and society. Their numerous accolades, including UK University of the Year, highlight their commitment to excellence and innovation within the education sector. The university also offers various scholarships and online learning programs to promote access to education. Their active engagement in research, with almost 90% rated 'world leading' or 'internationally excellent', suggests a strong focus on academic advancement and creating tangible impact through research outcomes.
University of Tokyo Innovation Platform (UTokyoIPC)
UTokyo Innovation Platform (UTokyoIPC) is the first investment firm wholly owned by the University of Tokyo, established in 2016. It aims to foster an innovation ecosystem originating from academia by supporting startups from creation to growth. The firm seeks to translate research and knowledge from the University of Tokyo and other research institutions into societal impact, creating new industries and value. They believe that innovation requires collaboration between researchers, entrepreneurs, investors, corporations, and government, leveraging the strengths of each to implement research outcomes and generate sustainable value. UTokyoIPC provides financial support and management assistance to university-based startups, fosters communities for entrepreneurs and researchers, develops collaborative programs with industry, and partners with international innovation hubs. This comprehensive approach aims to increase the number and growth rate of university-launched startups, enabling them to achieve both domestic and international recognition. They are evolving from a traditional investment company to an ecosystem builder, offering not just funding but also industry-academia collaboration and talent development programs to nurture the next generation of innovators. The firm's mission is to create an environment where researchers and entrepreneurs can confidently pursue their ventures, translating academic knowledge into societal applications and industrial advancements. This process encourages talent development, capital circulation, and the emergence of new challenges. UTokyoIPC aims to be a foundational company that supports the long-term growth of university-driven innovation, striving to create a societal base that cultivates the seeds of challenge into future achievements. Their focus lies in addressing societal challenges through deep tech ventures in areas like climate change, natural disasters, aging populations, food shortages, and energy crises.
University of Twente
Based on the provided website content, it is challenging to define a specific investment thesis or strategy for the University of Twente. The University of Twente is a research university in Enschede, Netherlands. The university's primary focus is on education and research in areas such as engineering, natural sciences, and social sciences. The website highlights various degree programs, research institutes, and collaboration opportunities, indicating an interest in fostering innovation and development in these fields. However, the information does not explicitly state a venture capital investment thesis or detail specific investment strategies. While the university facilitates research and offers collaboration opportunities with businesses, it does not directly present itself as a venture capital firm. The website showcases research institutes and encourages collaborations with external partners. These activities might lead to the development of technologies or startups that could be of interest to venture capitalists, but the university itself is not presented as an investment vehicle. The university's engagement with external parties through collaborations and research support suggests a potential interest in commercializing research outcomes. However, the website lacks specific details about investment criteria, target sectors, or financial instruments. Therefore, it is difficult to determine their investment approach without additional information.
Unknown Group
Unknown Group focuses on supporting entrepreneurs who are building solutions for a better world. They are constructing what they claim to be the largest impact campus in Europe, centered around a leading university for entrepreneurs. Their strategy includes identifying exceptional founders through initiatives like "Get in the Ring" and supporting their growth through campus facilities and university programs. They emphasize providing a physical space for founders to work, connect, and test solutions, alongside educational opportunities to further develop their businesses. The core of their investment and support strategy involves creating an ecosystem designed to foster the development of impactful and sustainable businesses.
Unovis Asset Management
Unovis Asset Management focuses on impact investing in purpose-driven food entrepreneurs. They aim to find, fund, and foster solutionary ideas globally, from disruptive start-ups to global conglomerates, sharing a vision for a well-fed and sustainable world. Their investment strategy involves sourcing opportunities, building collaborative global partnerships, connecting source funding, and establishing lasting partnerships, providing fundamental support from seed stage onward. They empower companies that are redefining how to sustainably feed the planet by funding innovations along the alternative protein production value chain. They focus on innovations in Protein R&D (Crops, Seeds, Microbes, Yeast, Fungi, Algae, Biomatter, Recombinant Proteins, Cultured Proteins, Tailored Fats, Allergen-Free Functional Ingredients and other Novel Ingredients), Product Development (Blending Culinary Arts with Food Science, Re-Envisioning Traditional Dishes, Crafting Winning Recipes), Protein Manufacturing (Biomass Fermentation, Precision Fermentation, Protein Isolation and Formulation, Shear Cell Processing, Ingredient Upcycling), Food Manufacturing (Layering, Extrusion, Food Processing, Dehydration, Spinning Fibers, 3D Printing) and Consumer Goods/Foodservice (Disruptive Brands, Innovative Distribution Models, Sustainable Packaging). Impact is the bedrock, measured by UN Sustainable Development Goals, ESG mandates, Diversity, Equity, and Inclusion, and Animal welfare.
Unreasonable Collective
Based on the crawled content, Unreasonable Collective appears to be associated with Unreasonable Group, which focuses on supporting and amplifying impactful companies and initiatives. The articles suggest a strong emphasis on community building, global collaboration, and addressing significant global challenges such as food security through investments in innovative solutions like sustainable aquaculture. The firm's activities appear to extend beyond pure financial investment, including creating content, guides, and hosting events to foster collaboration and knowledge sharing. Their content highlights operational strategies like running effective brainstorm sessions and aligning global teams, suggesting a hands-on approach to supporting ventures.
Unruly Capital
Unruly Capital positions itself as a venture capital fund that operates differently, offering transparency through its public web dashboard. The firm seems to have a broad investment mandate, participating in diverse sectors such as Health, BioHealth, and Climate. They are actively deploying capital, having invested $19.6M out of a $23.9M fund across 73 investments. Their investment activity is relatively recent, indicated by the listed transactions up to January 2026. The firm publishes a manifesto that indicates a contrarian and independent spirit. Given the range of co-investors, Unruly Capital is likely willing to participate in syndicated deals with established firms. The data presented indicates an investment approach that is active and responsive to emerging opportunities. The dashboard publicly shares fund statistics, recent transactions, and visual representations of investment categories, investments per quarter, top investment locations, co-investors, and current portfolio companies. This transparency is core to their "doing things differently" approach. Given the sector information available (Climate, BioHealth, Health) and portfolio companies (Beyond Aero, Deep Science Ventures, Renaissance Fusion), it seems the fund has some inclination toward deep tech and impactful ventures. The fund's co-investors are impressive, showing that Unruly Capital is able to attract high-caliber capital allocators. Further research would be needed to flesh out all aspects of the fund's investment strategy.
Urban Pioneers
The Essential Wardrobe (Garderoben som varer) Bruno r-neck[](/no-no/products/bruno-r-neck-tee-t-shirt)[Bruno r-neck](/no-no/products/bruno-r-neck-tee-t-shirt)Ordinær pris499,00 krSalgsprisOrdinær pris499,00 krEnhetspris/perOrdinær pris499,00 krSalgsprisOrdinær pris499,00 krEnhetspris/perBLACKBLUE BONNETCAPTAINS BLUECOCOLATE CHIPCORAL REEFDARK FORESTDARK GRAY MELANGEFOREST NIGHTFUDGEHEDGE GREENINFINITYLIGHT SANDNAVYOYSTER GREYWHITE
Utrecht Health Seed Fund
Utrecht Holdings Seed Fund (UHSF) invests in science-based startups originating from or closely linked to Utrecht University (UU) and University Medical Centre Utrecht (UMCU). The fund builds upon the success of the UtrechtHealthSeed Fund (UHSF I). Their primary aim is to translate scientific research into broader societal impact by providing early-stage funding to innovative companies. They are committed to supporting ventures that address pressing challenges in healthcare and sustainability, with a focus on creating impactful solutions leveraging cutting-edge research and technologies from UU and UMCU. The fund's investment strategy reflects the research strengths of its investors, primarily focusing on Life Sciences/MedTech, Digital Innovation, and Sustainability. UHSF seeks to bridge the gap between academic research and commercial application by providing crucial seed funding to spin-offs and startups that have demonstrated a clear potential for scalability and positive impact. They are actively looking for opportunities where the innovations are deeply rooted in scientific breakthroughs. The fund invests in companies located in the Netherlands, particularly those connected to the Utrecht ecosystem. They are especially interested in innovations coming from and linked to Utrecht University and University Medical Center Utrecht. The firm intends to foster an environment where early-stage ventures can thrive by providing not only financial backing but also leveraging the vast network, knowledge base, and infrastructure of Utrecht Holdings, Utrecht University and UMCU. The goal is to advance translational science, fostering the growth of innovative businesses and contributing to economic development in the region. UHSF is managed by Utrecht Holdings, the Knowledge Transfer Office of the UU and UMCU, further cementing the alignment with the strategic research priorities and ensuring a close relationship with the source of innovative technologies. The fund seeks to create an ecosystem where academic research can be translated into tangible benefits for society and is actively involved in nurturing and mentoring companies in the early stages. They operate with a collaborative mindset, partnering with other investors and stakeholders to maximize the chances of success for their portfolio companies.
Utrecht Holdings
Utrecht Holdings bridges the gap between academic research and market application by supporting researchers from Utrecht University and UMC Utrecht. The firm provides legal, strategic, and financial backing to transform inventions—such as therapies, sustainable materials, or AI applications—into viable products or ventures, including patenting, partner matching, and early-stage funding (up to €25,000 via the *Make It Matter* voucher program).
V-Bio Ventures
V-Bio Ventures is a life science venture capital fund that focuses on co-creating startups and investing in early- to mid-stage companies with high growth potential. Their core mission is to transform scientific innovation into products that positively impact people’s lives. The firm's investment strategy centers on identifying and supporting companies with differentiated technology addressing unmet needs. They actively seek innovative and transformational technologies with high societal and/or environmental impact potential within the therapeutics sector, encompassing both drug discovery and drug development. V-Bio Ventures leverages its extensive network and sector expertise to provide more than just capital. They aim to be an integral part of the ventures they back, contributing actively to their development. A preferred relationship with VIB, a prominent life science research institute in Belgium, serves as a key source for co-created companies built on VIB-derived innovations. However, they also source deals from research institutes, entrepreneurial initiatives, and spin-outs from established companies across Europe. The firm has a broad investor base that includes financial institutions, governmental bodies, private family offices, and academic institutions. A portion of their funds are supported by InnovFin Equity, backed by the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI), which aims to facilitate financing and implementation of productive investments in the European Union and increase access to financing. Overall, V-Bio Ventures focuses on building a healthier future by investing in companies that leverage great science and empowering talented entrepreneurs. The firm supports its portfolio companies with capital and expertise, facilitating the transformation of scientific innovations into impactful solutions.
VF Venture (Vækstfonden)
VF Venture (Vækstfonden), now operating under the name Danmarks Eksport- og Investeringsfond (EIFO), positions itself as Denmark's business bank and investment fund. Their core mission is to assist Danish companies in 'setting things in motion,' implying a focus on enabling growth and innovation across various sectors. EIFO's strategic priorities are centered around bolstering Denmark's economy by addressing key societal challenges and opportunities. These include strengthening national security, driving the green transition, fostering growth and entrepreneurship, and advancing innovative technologies. The fund aims to facilitate investments that generate substantial impact, not just financial returns, thereby contributing to the overall prosperity of Denmark. The fund's investment strategy is likely broad, encompassing multiple avenues for supporting Danish businesses. This is evidenced by their emphasis on providing 'capital to Danish companies,' as indicated by one of the visual elements on their main page. The specific investment instruments and mechanisms are not fully detailed in the provided text, however, the focus on both established businesses and startups suggests that they engage in a variety of funding approaches, ranging from debt financing to equity investments and potentially other forms of hybrid capital. EIFO's reported financial results, including a projected profit of 1.8 billion DKK in 2025 and the facilitation of 1.4 billion DKK in investments for Danish businesses, underscore the scale and impact of their operations. The campaign 'Sæt ting i gang' ('Set things in motion') further reinforces the firm’s commitment to actively shaping the Danish business landscape and stimulating economic activity across various sectors. The messaging targets both the entrepreneurial spirit of Danish companies and the fund’s proactive role in fostering growth.
VP Capital
VP Capital is a family office originating from Van Puijenbroek Textile, established in 1865. They have evolved into an impact-driven investor leveraging capital and network for positive change for the planet and society. Since 2019, they implemented a strategy focused on reducing negative impact and promoting positive change in sectors such as agrifood, real estate, textile, clean technology, and energy. Approximately half of their managed assets are allocated to impactful companies and innovative enterprises. Starting in 2024, VP Capital reshaped its strategy to put impact at the forefront of every decision, assessed through a financial lens. They structure their impact strategy around 3 key challenges and 6 solutions, guiding all investments based on their potential to drive these solutions and challenges. They aim to realize impact through their own organization, their capital investments and donations, and their influence as an investor by actively engaging with their investments and network on topics like biodiversity, climate change, and inequality. VP Capital's investments are long-term commitments, screened against criteria like purpose, vision, and intended impact. The due diligence process identifies financial, legal, and sustainability issues. They are actively involved with their investments, with a VP Capital team member holding a seat in a governing body in at least 75% of their assets to promote sustainability, impact, and innovation. They also maintain an exclusion list and actively work with their portfolio companies on actions to reduce negative impact. They invest across asset classes including private equity, ventures, real estate, and publicly traded businesses. Investor additionality, potential impact, and realized impact are key in their decision-making process. They support companies that drive the future of sustainability by providing not only financial support but also sharing valuable knowledge, experience, and extensive networks. VP Capital has adopted an impact-first investment strategy, inspired by Kate Raworth’s Doughnut model, to achieve a balance between social needs and planetary limits. Their investment strategy starts with impact objectives and translated into asset class targets for capital allocation to the six solutions tied to their three impact themes.
VP Venture Partners
VP Venture Partners is a Zurich-based VC firm focused on supporting early-stage life science companies in Europe. They aim to significantly impact the European life science ecosystem by providing not only financing but also hands-on support through building, coaching, and assisting startups from the pre-seed or seed stage to exit. Their investment philosophy revolves around a hands-on approach, offering deep due diligence, relationship building, and intensive coaching even before investment. The firm prioritizes deep tech life science companies, specifically within human life science ventures, including medical devices, digital health, and diagnostics. They explicitly exclude therapeutics and drug development from their investment scope. Their investment decisions are driven by areas of unmet need with a high potential patient impact, coupled with the presence of dedicated, motivated, and skilled teams with a passion for bringing their product to market. VP Venture Partners emphasizes collaborative, data-informed decision-making grounded in scientific evidence. They are willing to take interim C-level positions and board positions to provide operational, entrepreneurial, financial, and scientific experience. Their due diligence involves challenge retreats to build strong relationships and provide actionable feedback, indicative of their commitment to working closely with their portfolio companies. Ultimately, VP Venture Partners seeks to generate a big impact for both patients and founders by offering comprehensive support and strategic guidance throughout the startup's journey, thereby fostering growth and success within the European life science sector.
VR Equitypartner
VR Equitypartner specializes in tailored financing solutions for mid-sized German companies, focusing on succession planning, growth expansion, and platform scaling. They provide flexible capital structures (e.g., mezzanine, direct equity) to support operational scaling, internationalization, and ownership transitions across diverse sectors.
VTC Ventures
Middleland Capital invests in companies driving transformative change in food and health through cutting-edge technology, sustainability, and operational efficiency. Focused on high-growth startups with proven traction, the firm targets sectors like plant resilience, microbiome science, soil optimization, and AI-driven agricultural solutions.
Vaaka Partners
Based on the limited information available, Vaaka Partners' primary focus seems to be on building "Business Champions." This suggests an investment strategy centered around identifying and supporting companies with high growth potential. Their stated approach emphasizes "Integrity + Growth", indicating a commitment to ethical business practices alongside rapid expansion. The firm seems to actively manage their portfolio companies, working closely with them to scale their businesses. They highlight their investments with logos such as Lemontree, Axitare, Fluxio Isannointi, Huutokaupat.com, Bolt Works, and Medbase which suggests they invest across different sectors. They also emphasize the importance of creating value and improving the long-term success of their businesses.
Valkea
Valkea invests in mission-driven startups revolutionizing energy, resource efficiency, and sustainability for a cleaner future.